EQRx (EQRX)

EQRx Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EQRX

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
20/11/2023	21:00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:EQRX	EQRx Inc
20/11/2023	05:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EQRX	EQRx Inc
20/11/2023	05:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EQRX	EQRx Inc
20/11/2023	05:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:04	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:03	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:01	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:EQRX	EQRx Inc
09/11/2023	21:01	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:EQRX	EQRx Inc
09/11/2023	14:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQRX	EQRx Inc
08/11/2023	16:30	GlobeNewswire Inc.	Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition	NASDAQ:EQRX	EQRx Inc
06/11/2023	21:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQRX	EQRx Inc
01/11/2023	12:02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EQRX	EQRx Inc
01/11/2023	11:59	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/11/2023	11:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQRX	EQRx Inc
16/08/2023	13:07	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
08/08/2023	22:29	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
08/08/2023	22:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQRX	EQRx Inc
03/08/2023	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQRX	EQRx Inc
01/08/2023	21:38	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	21:32	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	21:31	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	21:29	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	12:25	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	12:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQRX	EQRx Inc
01/08/2023	12:00	GlobeNewswire Inc.	Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital	NASDAQ:EQRX	EQRx Inc
03/07/2023	23:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQRX	EQRx Inc
08/05/2023	22:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EQRX	EQRx Inc
08/05/2023	21:01	GlobeNewswire Inc.	EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results	NASDAQ:EQRX	EQRx Inc